Showing 19,881 - 19,900 results of 67,583 for search '(( a fold decrease ) OR ( 5 ((point decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 1.26s Refine Results
  1. 19881
  2. 19882
  3. 19883
  4. 19884

    DataSheet1_Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models.docx by Andrée-Anne Poirier (13138635)

    Published 2022
    “…This suggests that drug repurposing of dutasteride might be a promising avenue to treat enteric neuroinflammation in early PD.…”
  5. 19885

    DataSheet5_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.ZIP by Mi Zhou (9884)

    Published 2024
    “…</p><p>Results: Valsartan rescued LPS-reduced cell viability of BEAS-2B cells, improved the pulmonary function, ameliorated pathological lung injury in mice with ALI, ameliorated LPS-induced neutrophil recruitment in BALF and lung tissue of mice, attenuated oxidative stress by increasing the level of SOD and decreasing that of MDA and GSSG, inhibited LPS-induced MUC5AC overproduction, decreased the LPS-induced increase in expression of pro-inflammatory cytokines/chemokines including TNF-α, IL-6, IL-1β, CXCL-1 and CXCL-2, and restored the expression of anti-inflammatory IL-10. …”
  6. 19886
  7. 19887
  8. 19888
  9. 19889

    Video_5_Aging dysregulates neutrophil extracellular trap formation in response to HIV in blood and genital tissues.mp4 by Laura Moreno de Lara (12966254)

    Published 2023
    “…HIV induced NET formation through non-lytic pathways in blood and FGT neutrophils, except for a small subset of NETs that incorporated annexin V and lactoferrin predominantly in blood, suggesting proinflammatory and lytic NET release. …”
  10. 19890
  11. 19891
  12. 19892

    Extracellular thiol isomerase ERp5 regulates integrin αIIbβ3 activation by inhibition of fibrinogen binding by Kaifei Sun (20640949)

    Published 2025
    “…In this study, we used a new ERp5-knockout mouse model as well as recombinant ERp5 (rERp5) protein, to examine the role of ERp5 in platelet function and thrombosis. …”
  13. 19893

    Table_1_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.xlsx by Ryousuke Kasai (14577584)

    Published 2023
    “…</p>Conclusion<p>Intensity and latency of antibody response were suppressed in patients with MDs. Although MDs may be a key contributor in predicting the antibody response to SARS-CoV-2 vaccination, SARS-CoV-2 immunization in MDs needs extensive research.…”
  14. 19894

    DataSheet_1_Tlr5 deficiency exacerbates lupus-like disease in the MRL/lpr mouse model.pdf by Razan M. Alajoleen (17630292)

    Published 2024
    “…We previously reported upregulation of anti-flagellin antibodies in the blood of lupus patients and lupus-prone mice, which led to our hypothesis that a leaky gut drives lupus through bacterial flagellin-mediated activation of toll-like receptor 5 (TLR5).…”
  15. 19895

    Image_3_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg by Ryousuke Kasai (14577584)

    Published 2023
    “…</p>Conclusion<p>Intensity and latency of antibody response were suppressed in patients with MDs. Although MDs may be a key contributor in predicting the antibody response to SARS-CoV-2 vaccination, SARS-CoV-2 immunization in MDs needs extensive research.…”
  16. 19896
  17. 19897

    Image_6_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg by Ryousuke Kasai (14577584)

    Published 2023
    “…</p>Conclusion<p>Intensity and latency of antibody response were suppressed in patients with MDs. Although MDs may be a key contributor in predicting the antibody response to SARS-CoV-2 vaccination, SARS-CoV-2 immunization in MDs needs extensive research.…”
  18. 19898
  19. 19899

    Image_2_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg by Ryousuke Kasai (14577584)

    Published 2023
    “…</p>Conclusion<p>Intensity and latency of antibody response were suppressed in patients with MDs. Although MDs may be a key contributor in predicting the antibody response to SARS-CoV-2 vaccination, SARS-CoV-2 immunization in MDs needs extensive research.…”
  20. 19900

    Image_1_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg by Ryousuke Kasai (14577584)

    Published 2023
    “…</p>Conclusion<p>Intensity and latency of antibody response were suppressed in patients with MDs. Although MDs may be a key contributor in predicting the antibody response to SARS-CoV-2 vaccination, SARS-CoV-2 immunization in MDs needs extensive research.…”